Savant Capital LLC increased its position in shares of Humana Inc. (NYSE:HUM) by 1.3% during the second quarter, Holdings Channel reports. The firm owned 2,380 shares of the insurance provider’s stock after buying an additional 30 shares during the period. Savant Capital LLC’s holdings in Humana were worth $428,000 as of its most recent filing with the SEC.
A number of other large investors also recently made changes to their positions in the stock. Daiwa SB Investments Ltd. raised its position in Humana by 7.5% in the second quarter. Daiwa SB Investments Ltd. now owns 720 shares of the insurance provider’s stock worth $132,000 after buying an additional 50 shares during the period. Bessemer Group Inc. raised its position in Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock worth $183,000 after buying an additional 797 shares during the period. Spark Investment Management LLC acquired a new position in Humana during the first quarter worth $274,000. Rehmann Capital Advisory Group raised its position in Humana by 0.4% in the first quarter. Rehmann Capital Advisory Group now owns 1,506 shares of the insurance provider’s stock worth $276,000 after buying an additional 6 shares during the period. Finally, Trust Co raised its position in Humana by 12.4% in the first quarter. Trust Co now owns 1,720 shares of the insurance provider’s stock worth $315,000 after buying an additional 190 shares during the period. 93.24% of the stock is owned by institutional investors and hedge funds.
Humana Inc. (NYSE:HUM) traded up 0.33% during trading on Wednesday, reaching $177.80. The company’s stock had a trading volume of 1,040,002 shares. Humana Inc. has a 1-year low of $150.00 and a 1-year high of $191.65. The stock has a 50 day moving average price of $176.95 and a 200 day moving average price of $176.09. The stock has a market capitalization of $26.50 billion, a PE ratio of 27.32 and a beta of 0.90.
Humana (NYSE:HUM) last issued its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.23 by $0.07. The company earned $14 billion during the quarter, compared to analysts’ expectations of $13.59 billion. Humana had a return on equity of 11.11% and a net margin of 1.76%. The firm’s quarterly revenue was up 2.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.67 EPS. Analysts anticipate that Humana Inc. will post $9.24 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be issued a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 0.65%. The ex-dividend date is Tuesday, October 11th. Humana’s payout ratio is currently 18.18%.
HUM has been the subject of a number of recent research reports. Zacks Investment Research lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday, September 21st. JPMorgan Chase & Co. lowered shares of Humana from an “overweight” rating to a “neutral” rating and cut their target price for the company from $196.00 to $150.00 in a report on Friday, July 8th. Evercore ISI initiated coverage on shares of Humana in a report on Thursday, September 22nd. They issued a “buy” rating and a $200.00 target price for the company. Argus reissued a “hold” rating on shares of Humana in a report on Tuesday, August 23rd. Finally, Wolfe Research raised shares of Humana to an “outperform” rating and set a $192.00 target price for the company in a report on Thursday, July 21st. Five equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $201.00.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.